5,000-Patient study to see which brain aneurysm devices work best

NCT ID NCT07175519

Recruiting now Knowledge-focused Sponsor: King's College London Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will follow 5,000 people who receive newer endovascular devices (like coils, stents, or flow diverters) to treat a brain aneurysm. Researchers want to see how often the aneurysm comes back and what factors, such as smoking, might play a role. The goal is to improve safety and long-term success of these treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: endovascular devices (coils, stents, flow diverters, intrasaccular devices)
What this could lead to: If successful, this could help doctors choose the best device for each patient and reduce the chance of aneurysms coming back.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove one device is better than another. Results may take years and depend on many patient factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain aneurysm intracerebral hemorrhage Intracranial Hemorrhages stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN ANEURYSM INTRACRANIAL HEMORRHAGES STROKE

Contacts and locations

Locations

Kings College Hospital, London
RECRUITING

London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.